Xipere (triamcinolone acetonide) injectable suspension, from Bausch + Lomb, is indicated for the treatment of macular edema associated with uveitis.
Triamcinolone acetonide is a corticosteroid that reduces inflammation. Xipere is administered via a suprachoroidal injection, delivering the corticosteroid directly to the choroid and outer retina to reduce the macular edema and inflammation associated with uveitis, while aiming to limit exposure to other structures of the eye.
Xipere may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:
The order is confirmed only after receipt and verification of a valid prescription.
Xipere is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).
Indian Pharma Network (IPN) can source Xipere from its authorized distribution network and facilitate supply to patients, doctors, and hospitals under applicable legal provisions.
For Xipere cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.
Xipere treats macular edema associated with uveitis.
Xipere is developed by Bausch + Lomb.
By suprachoroidal injection, administered by an ophthalmologist, dosed per the treatment protocol.
Cost depends on treatment frequency and sourcing logistics — share your prescription with IPN for a quote.
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.
